Kamal M. Matar

512 total citations
41 papers, 436 citations indexed

About

Kamal M. Matar is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Analytical Chemistry. According to data from OpenAlex, Kamal M. Matar has authored 41 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 17 papers in Pediatrics, Perinatology and Child Health and 11 papers in Analytical Chemistry. Recurrent topics in Kamal M. Matar's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Analytical Methods in Pharmaceuticals (11 papers). Kamal M. Matar is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Analytical Methods in Pharmaceuticals (11 papers). Kamal M. Matar collaborates with scholars based in Kuwait, Saudi Arabia and United Kingdom. Kamal M. Matar's co-authors include M. I. AL‐HASSAN, Paul J. Nicholls, S. A. Bawazir, A. Tekle, Mohammed E. Abdel‐Hamid, Tawfeeg A. Najjar, Yasin Tayem, Roger W. Jelliffe, Salem Alshemmari and Samuel B. Kombian and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Kamal M. Matar

37 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kamal M. Matar Kuwait	12	161	139	136	135	62	41	436
W. D. Paar Germany	8	178 1.1×	119 0.9×	82 0.6×	84 0.6×	43 0.7×	14	537
Hana Brozmanová Czechia	15	149 0.9×	247 1.8×	168 1.2×	84 0.6×	63 1.0×	65	645
Simon N. Muchohi Kenya	15	118 0.7×	234 1.7×	216 1.6×	60 0.4×	39 0.6×	24	646
JoEtta M. Juenke United States	12	123 0.8×	111 0.8×	109 0.8×	74 0.5×	29 0.5×	24	327
Joana Sousa Portugal	8	157 1.0×	58 0.4×	58 0.4×	89 0.7×	73 1.2×	18	446
L. G. Gisclon United States	10	228 1.4×	218 1.6×	158 1.2×	47 0.3×	17 0.3×	16	579
M. Guyot France	12	40 0.2×	69 0.5×	54 0.4×	61 0.5×	43 0.7×	22	552
Régis Bouquié France	14	171 1.1×	67 0.5×	33 0.2×	41 0.3×	24 0.4×	33	498
H Vergin Switzerland	11	177 1.1×	29 0.2×	54 0.4×	95 0.7×	54 0.9×	56	544
Huybrecht T’jollyn Belgium	9	145 0.9×	51 0.4×	39 0.3×	37 0.3×	26 0.4×	14	302

Countries citing papers authored by Kamal M. Matar

Since Specialization

Citations

This map shows the geographic impact of Kamal M. Matar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamal M. Matar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamal M. Matar more than expected).

Fields of papers citing papers by Kamal M. Matar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kamal M. Matar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamal M. Matar. The network helps show where Kamal M. Matar may publish in the future.

Co-authorship network of co-authors of Kamal M. Matar

This figure shows the co-authorship network connecting the top 25 collaborators of Kamal M. Matar. A scholar is included among the top collaborators of Kamal M. Matar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamal M. Matar. Kamal M. Matar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matar, Kamal M., et al.. (2024). Rhabdomyolysis Induced by Levetiracetam: A Case Report in Kuwait. SHILAP Revista de lepidopterología. 2024(1). 1234738–1234738.

Awaisu, Ahmed, et al.. (2024). Pharmacokinetics of single‐dose rivaroxaban under fed state in obese vs. non‐obese subjects: An open‐label controlled clinical trial (RIVOBESE‐PK). Clinical and Translational Science. 17(6). e13853–e13853.

Matar, Kamal M., et al.. (2023). Impact of valproic acid on busulfan pharmacokinetics: In vitro assessment of potential drug-drug interaction. PLoS ONE. 18(1). e0280574–e0280574.

Matar, Kamal M. & Yasin Tayem. (2014). Effect of Experimentally Induced Hepatic and Renal Failure on the Pharmacokinetics of Topiramate in Rats. BioMed Research International. 2014. 1–5. 9 indexed citations

Matar, Kamal M.. (2013). Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits. BioMed Research International. 2013. 1–5. 2 indexed citations

Matar, Kamal M., et al.. (2011). Effect of pregnancy on topiramate pharmacokinetics in rabbits. Xenobiotica. 41(5). 416–421. 3 indexed citations

Matar, Kamal M., Ahmed Z. El‐Hashim, & Ivan O. Edafiogho. (2010). Liquid chromatography‐tandem mass spectrometric method for determination of E121 in mouse plasma and its application to pharmacokinetics. Journal of Separation Science. 33(13). 1888–1896. 3 indexed citations

Matar, Kamal M.. (2010). Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta. 411(9-10). 729–734. 27 indexed citations

Matar, Kamal M., et al.. (2010). Galvanostatic Stripping Chronopotentiometric Study for Determination of Selenium: Pharmacokinetic Application in Experimental Mice. Journal of Pharmacy & Pharmaceutical Sciences. 13(3). 391–391. 1 indexed citations

10.

Matar, Kamal M.. (2008). Quantification of levetiracetam in human plasma by liquid chromatography–tandem mass spectrometry: Application to therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 48(3). 822–828. 53 indexed citations

11.

Abdel‐Hamid, M. E., et al.. (2007). Therapeutic Drug Monitoring of Gentamicin: Evaluation of Five Nomograms for Initial Dosing at Al-Amiri Hospital in Kuwait. Medical Principles and Practice. 16(5). 348–354. 8 indexed citations

12.

Matar, Kamal M.. (2005). Influence of famotidine on verapamil pharmacokinetics in rats. European Journal of Drug Metabolism and Pharmacokinetics. 30(3). 219–222. 2 indexed citations

13.

Matar, Kamal M., et al.. (2004). Isoniazid acetylation phenotyping in Saudi Arabs. Journal of Clinical Pharmacy and Therapeutics. 29(5). 443–447. 11 indexed citations

14.

Matar, Kamal M., et al.. (2001). Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs. European Journal of Drug Metabolism and Pharmacokinetics. 26(3). 149–153. 1 indexed citations

15.

Matar, Kamal M., et al.. (2000). Effect of vigabatrin and gabapentin on phenytoin pharmacokinetics in the dog. Pharmacological Research. 42(6). 517–521. 4 indexed citations

16.

Matar, Kamal M., Paul J. Nicholls, A. Tekle, S. A. Bawazir, & M. I. AL‐HASSAN. (2000). Effect of vigabatrin and gabapentin on phynytoin pharmacokinetics in the dog. European Journal of Drug Metabolism and Pharmacokinetics. 25(3-4). 189–193. 1 indexed citations

17.

Matar, Kamal M., Paul J. Nicholls, A. Tekle, S. A. Bawazir, & M. I. AL‐HASSAN. (1999). Effects of Pregnancy on the Pharmacokinetics of Lamotrigine in Dogs. Epilepsia. 40(10). 1353–1356. 5 indexed citations

18.

AL‐HASSAN, M. I., et al.. (1993). The interaction potential of vigabatrin with phenytoin and carbamazepine. International Journal of Pharmaceutics. 93(1-3). 7–12. 5 indexed citations

19.

Najjar, Tawfeeg A., et al.. (1992). Comparison of a New High-Performance Liquid Chromatography Method with Fluorescence Polarization Immunoassay for Analysis of Methotrexate. Therapeutic Drug Monitoring. 14(2). 142–146. 22 indexed citations

20.

Bawazir, S. A., M. I. AL‐HASSAN, Kamal M. Matar, & A. Tekle. (1989). The effect of domperidone on theophylline disposition in the rat. Biopharmaceutics & Drug Disposition. 10(6). 531–535. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact